JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, F.
Right arrow Articles by Collins, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, F.
Right arrow Articles by Collins, M. K.

 Previous Article  |  Next Article 

Journal of Virology, February 2003, p. 2753-2756, Vol. 77, No. 4
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.4.2753-2756.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Targeted Retroviral Infection of Tumor Cells by Receptor Cooperation

Francisco Martin,1,{dagger} Simon Chowdhury,1 Stuart J. Neil,1 Kerry A. Chester,2 Francois-Loic Cosset,3 and Mary K. Collins1*

Department of Immunology and Molecular Pathology, Windeyer Institute,1 CRC Targeting and Imaging Group, Department of Oncology, Royal Free and University College Medical School, London, United Kingdom,2 Laboratoire Vectorologie Retrovirale et Therapie Genique, Unite de Virologie, Humaine, U412 INSERM, IFR 74 and ENS de Lyon, France3

Received 23 July 2002/ Accepted 14 November 2002

Retroviruses expressing two different receptor-binding domains linked by proline-rich spacers infect only cells expressing both retroviral receptors (Valsesia-Wittman et al., EMBO J. 6:1214-1223, 1997). Here we apply this receptor cooperation strategy to target human tumor cells by linking single-chain antibodies recognizing tumor antigens via proline-rich spacers to the 4070A murine leukemia virus surface protein.


* Corresponding author. Mailing address: Windeyer Institute, 46 Cleveland St., London W1T 2AH, United Kingdom. Phone and fax: 44-207-679-9301. E-mail: mary.collins{at}ucl.ac.uk.

{dagger} Present address: Unidad Mixta de Investigaciones Médicas, Hospital Clínico San Cecilio, Granada, Spain.


Journal of Virology, February 2003, p. 2753-2756, Vol. 77, No. 4
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.4.2753-2756.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.